Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-03

Clinical Trial Update: A New Prenatal Blood Test for Down Syndrome

View source ↗

Summary

A completed clinical trial evaluating a new prenatal blood test for detecting Down syndrome (trisomy 21) in fetuses has been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Down Syndrome, Trisomy 21 | Status: COMPLETED